| related words |
| convince |
| molecular |
| pti |
| inhibitor |
| skin |
| stent |
| questioned |
| factive |
| vancocin |
| researcher |
| alberta |
| surgeon |
| warning |
| hydrogen |
| dna |
| dacogen |
| diagnostics |
| multiferon |
| confirm |
| stem |
|
| related documents |
| 789860--6/29/2010--Yayi_International_Inc |
| 1084876--3/13/2009--RAE_SYSTEMS_INC |
| 1112412--3/14/2008--ENDEAVOUR_INTERNATIONAL_CORP |
| 1450922--3/31/2010--ETFS_SILVER_TRUST |
| 865231--3/1/2007--CELL_GENESYS_INC |
| 920448--3/27/2007--BROADVISION_INC |
| 1222333--11/25/2009--SPDR_GOLD_TRUST |
| 920448--6/9/2006--BROADVISION_INC |
| 1093649--3/16/2006--IDENIX_PHARMACEUTICALS_INC |
| 789860--2/16/2010--Yayi_International_Inc |
| 320333--3/31/2006--HANOVER_DIRECT_INC |
| 1112412--3/13/2006--ENDEAVOUR_INTERNATIONAL_CORP |
| 811240--3/16/2009--BIOLASE_TECHNOLOGY_INC |
| 865231--3/13/2006--CELL_GENESYS_INC |
| 1074447--3/18/2010--MANAS_PETROLEUM_Corp |
| 1093649--3/14/2008--IDENIX_PHARMACEUTICALS_INC |
| 1276591--2/28/2008--HANSEN_MEDICAL_INC |
| 1124289--3/31/2008--HAIGHTS_CROSS_COMMUNICATIONS_INC |
| 1084876--3/12/2010--RAE_SYSTEMS_INC |
| 838879--3/31/2008--AMDL_INC |
|
| related topics |
| {product, liability, claim} |
| {control, financial, internal} |
| {property, intellectual, protect} |
| {product, candidate, development} |
| {gas, price, oil} |
| {customer, product, revenue} |
| {cost, regulation, environmental} |
| {regulation, change, law} |
| {stock, price, operating} |
| {cost, contract, operation} |
| {financial, litigation, operation} |
| {interest, director, officer} |
| {system, service, information} |
| {stock, price, share} |
| {regulation, government, change} |
| {competitive, industry, competition} |
| {cost, operation, labor} |
| {loan, real, estate} |
| {provision, law, control} |
| {acquisition, growth, future} |
|